Characterization of phloroglucinol derivatives and diterpenes in Euphorbia ebracteolata Hayata by utilizing ultra-performance liquid chromatography/quadrupole time-of-flight mass spectrometry  by Wang, Can-Jian et al.
Contents lists available at ScienceDirect
www.elsevier.com/locate/jpa
Journal of Pharmaceutical Analysis
Journal of Pharmaceutical Analysis 2013;3(4):292–2972095-1779 & 2013 Xi
http://dx.doi.org/10.10
nCorresponding aut
E-mail addresses:
jiangyq@gzfda.gov.cn
Peer review under rwww.sciencedirect.comSHORT COMMUNICATION
Characterization of phloroglucinol derivatives and
diterpenes in Euphorbia ebracteolata Hayata by utilizing
ultra-performance liquid chromatography/quadrupole
time-of-ﬂight mass spectrometryCan-Jian Wanga,b, Ying-Qiao Jianga,n, Dong-Hui Liub, Xiao-Hong Yana,
Shuang-Cheng MAcaGuangzhou Institute for Drug Control, Guangzhou 510160, China
bGuangzhou University of Chinese Medicine, Guangzhou 510405, China
cNational Institute for Control of Pharmaceutical and Biological Products, Beijing 100050, China
Received 20 April 2012; accepted 8 January 2013
Available online 21 March 2013KEYWORDS
Phloroglucinol
derivatives;
Diterpenes;
Euphorbia ebracteolata
Hayata;
UPLC-Q-TOF/MS’an Jiaotong Univer
16/j.jpha.2013.01.00
hor. Tel.: þ86 20 26
wangcanjianabc@16
(Y.-Q. Jiang)
esponsibility of Xi’Abstract Euphorbia ebracteolata Hayata (E. ebracteolata) is a Chinese herbal medicine used for the
treatment of tumor diseases. An ultra-performance liquid chromatography/quadrupole time-of-ﬂight mass
spectrometry (UPLC–Q–TOF/MS) based chemical proﬁling approach was established for the rapid
separation and characterization on phloroglucinol derivatives and diterpenes in E. ebracteolata. Three
phloroglucinol derivatives and nine diterpenes were identiﬁed by exact mass measurement and were
further conﬁrmed by Ms2 data. In addition, the chemical proﬁles of six compounds were acquired by
reference standards. Furthermore, the fragmentation rules of phloroglucinol derivatives and diterpenes of
E. ebracteolata were analyzed, and each chromatographic peak was classiﬁed.
& 2013 Xi’an Jiaotong University. Production and hosting by Elsevier B.V. All rights reserved.sity. Production and hosting by Else
2
282045; fax: þ86 20 26283096.
3.com (C.-J. Wang),
an Jiaotong University.1. Introduction
Euphorbia ebracteolata Hayata, a Chinese herb Langdu, has an
effect of dissipating binds and insecticidal action. It is mainly used
for treatment of scrofula, psoriasis [1]. The major constituents of
E. ebracteolata include terpenoids, phloroglucinol derivatives,
ﬂavonoids, and sterols [2]. In the present study, we focus on the
phloroglucinol derivatives and diterpenes. Diterpenes play an
important role in the prevention of human diseases. The mostvier B.V. All rights reserved.
Phloroglucinol derivatives and diterpenes in E. ebracteolata 293prominent effects of the diterpenes in E. ebracteolata are
antitumor, antibacteria and immune adjustment [3–5]. The struc-
tures of these phloroglucinol derivatives and diterpenes are
summarized in Scheme 1. Conventional phytochemical
approaches, which are time-consuming, have been used for
studying the structures of phloroglucinol derivatives and diter-
penes in E. ebracteolata [6–9]. To our knowledge, ultra-
performance liquid chromatography/quadrupole time-of-ﬂight
mass spectrometry (UPLC–Q–TOF/MS), as a powerful hyphe-
nated technique, has never been used to elucidate the structures of
active compounds in E. ebracteolata.
In this study, we reported on the identiﬁcation of phloroglucinol
derivatives and diterpenes in the crude extract of E. ebracteolata
by UPLC–Q–TOF/MS in positive-ion mode. Six reference che-
micals, for example 2,4-dihydroxy-6-methoxy-3-methyl-acetophe-
none, were selected for characterization of the main components ofO
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Fig. 1 HPLC and ESI-MS chromatograms of E. ebracteolata: (A) HP
positive mode.E. ebracteolata for the ﬁrst time. The mass spectral fragmentations
of phloroglucinol derivatives and Jolkinolides abietane lactone in
E. ebracteolata were discussed as well.2. Materials and methods
2.1. Chemicals and materials
HPLC grade acetonitrile (Merck, Darmstadt, Germany), formic
acid (CNW, Germany) were used, and ultra-pure water was
prepared using a Milli-Q water puriﬁcation system (Bedford,
MA, USA). Ethanol (AR grade) for sample extraction was purchased
from Guangzhou Chemical Reagent Factory (Guangzhou,
China). All solvents were ﬁltered through 0.22 mm membrane ﬁlters
before analysis.O
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tion pathway of Jolkinolide B.
LC chromatogram at 226 nm and (B) ESI-MS chromatogram in the
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C.-J. Wang et al.294The herbal medicine E. ebracteolata was obtained from Liaoning
Institute for Food and Drug Control (China) and was identiﬁed by
chief pharmacist Boying Liu. A voucher specimen was deposited
in Guangzhou Institute for Drug Control (Guangzhou, China).
The reference standards of 2,4-dihydroxy-6-methoxy-3-methylaceto-
phenone, 2,2′,4,4′-tetrahydroxy-6,6′-dimethoxy-3,3′-dimethyl-7,5′-
bisacetophenone, 3,3′-diacetyl-4,4′-dimethoxy-2,2′,6,6′-tetrahydroxy-
diphenylmethane, Jolkinolide A, Jolkinolide B and Yuexiandujisu D
were obtained from Institute for Chinese Medicine and Natural
Medicine, Pharmacy College, Jinan University (Guangzhou, China).
2.2. Sample preparation
The herbal materials were ground into a ﬁne powder (through a
sieve of 100 meshes). An aliquot of 1 g of E. ebracteolata,
accurately weighed, was extracted for 30 min with 25 mL of
ethanol on an ultrasonic water bath (30 1C), and the extract was
then ﬁltered through a 0.22 μm syringe ﬁlter. The successive
ﬁltrate was used as the test solution.
2.3. Analytical method
Liquid chromatography was performed with an Agilent-1200
UPLC system (Agilent Corp., USA), equipped with a quaternary
pump, UV detector, autosampler and column compartment.
The column was an Agilent ZORBAX SB-C18 column
(3.0 mm 100 mm, I.D., 5 μm). The mobile phase consisted of
(A) 0.1% formic acid in water and (B) acetonitrile (ACN). The
UPLC elution condition was optimized as follows: 30%–65% B
(0–20 min), 65%–75% B (20–30 min), 75%–85% B (30–35 min),
85% B (35–60 min) and isocratic at 30% B (60–63 min). The
ﬂow rate was at 0.4 mL/min. The column was maintained at
20 1C, and the injection volume of reference compounds and
samples was 2 mL. The analytes were monitored at 226 nm.
LC–MS detection was performed directly after UV measure-
ments, which was performed by an Agilent 6538 UHD Accurate-
Mass Q–TOF/MS (Agilent Corp., USA) equipped with an ESI
interface. The TOF/MS analysis was performed using full scan
mode and mass range was set at m/z 50–1700 in positive-ion
mode. The conditions of ESI source were as follow: drying gas
(N2) ﬂow rate, 10 L/min; drying gas temperature, 350 1C;
Nebulizer, 40 psig, capillary voltage, 4000 V; fragmentor voltage,
175 V; skimmer voltage, 65 V; octopole RF, 750 V. All the data
were processed by Agilent MassHunter Software Ver. B. 03.01.
Tuning mix was used for lock mass calibration in our assay.3. Results and discussion
3.1. Optimization of HPLC and mass spectrometry conditions
To obtain desirable HPLC chromatograms, the procedure of
sample preparation was optimized in selecting the extraction
solvent. Three concentrations of aqueous ethanol, 50% (v/v in
water), 70% and 95% were used for sample preparation. As no
signiﬁcant difference was observed among the obtained chroma-
tograms, we selected 95% aqueous ethanol as the extraction
solvent for this study. Among the ﬁve columns (Zorbax SB-C18,
Dikma-C18, Ecosil-C18, Grace-C18 and Phenomenex-C18) that
were tested for the separation of the sample, Zorbax SB-C18
column gave the best chromatographic resolution. 0.03% (v/v)
Phloroglucinol derivatives and diterpenes in E. ebracteolata 295formic acid was added to the mobile phase to improve the mass
spectrometry ionization efﬁciency and enable symmetric peak
shapes. The UV detection wavelength was set at 226 nm, at which
most components can be detected sensitively. Both the positive
and negative ion modes were tested for MS analysis.COCH3
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Fig. 2 Chemical structuresMost phloroglucinol derivatives and diterpenes showed much
cleaner mass spectral background and higher sensitivity in the
positive mode than in the negative mode. The HPLC chromato-
gram and LC/MS total ion current of E. ebracteolata extract are
given in Fig. 1.O
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Fig. 3 The MS2 spectra of compounds 1, 8 and 10.
Fig. 4 The MS2 spectra of compounds 2 and 3.
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Phloroglucinol derivatives and diterpenes in E. ebracteolata 2973.2. Rationale for the characterization of phloroglucinol
derivatives and diterpenes
The identity of known compounds in the herbal extract was
conﬁrmed by comparing with reference standards according to the
retention time and MS2 spectra [15]. The unknown compounds
were characterized by analyzing their fragmentation behaviors in
MS2 spectra and by referring to the available literature informa-
tion. A total of 12 compounds were characterized (Table 1), six
(1, 2, 8, 9, 10, and 11) of which were identiﬁed by comparing the
mass spectra and retention times with those of reference standards.
Jolkinolide E was reported from E. ebracteolata for the ﬁrst time.
The structures of conﬁrmed compounds are shown in Fig. 2.
3.3. Identiﬁcation of phloroglucinol derivatives
(compounds 1, 8 and 10)
Phloroglucinol derivatives were acetyl phenols containing hydroxyl,
methoxy and acetyl groups. The mass spectral data of phlorogluc-
inal derivatives showed a series of fragment ions apparently
produced by gradual losses of hydroxyl, acetyl and methoxy, and
ﬁve-membered-ring ion resulted from benzene ring cracking.
By comparing with mass spectra of a reference standard, compounds
1, 8 and 10 were identiﬁed as 2,4-dihydroxy-6-methoxy-3-methylaceto-
phenone, 2,2′,4,4′-tetrahydroxy-6,6′-dimethoxy-3,3′-dimethyl-7,5′-bisa-
cetophenone and 3,3′-diacetyl-4,4′-dimethoxy-2,2′,6,6′-tetrahydroxy-
diphenylmethane, respectively (Fig. 3).
3.4. Identiﬁcation of Jolkinolides type of ent-abietane lactone
(compounds 2, 3, 4, 9, 11 and 12)
A number of Jolkinolides type of ent-abietane lactones have been
reported from Euphorbia species [3]. These lactones are tetracyclic
diterpenoids, containing hydroxyl, epoxy groups. By comparison
to reference standards, compounds 2, 9 and 11 were identiﬁed as
Yuexiandujisu D, Jolkinolide B and Jolkinolide A, respectively.
A proposed pathway of Jolkinolide B was given in Scheme 1.
Compound 3 gave [MþH]þ at m/z 351. The MS/MS spectrum
showed the same cleavage pattern as Yuexiandujisu D (Fig. 4).
Thus, compound 18 was tentatively identiﬁed as isomers of
Yuexiandujisu D, named ebracteolatanolide B [12] or Yuexiandu-
jisu E [11]. The MS/MS spectra of compounds 4 ([MþH]þ at m/z
333) and 12 ([MþH]þ at m/z 301), showing neutral losses of H2O
and CO, were very similar to those of compounds 2, 9 and 11.
Compounds 4 and 12 were tentatively identiﬁed as ebracteolata-
nolide A [12] and Jolkinolide E [3], respectively.
3.5. Identiﬁcation of other free diterpenes (compounds 5, 6 and 7)
Compounds 5 and 6 gave [MþH]þ at m/z 305 and m/z 317,
respectively. The MS/MS spectra of both compounds showed a
similar fragmentation pathway with neutral losses of H2O and CO.Compounds 5 and 6 were tentatively identiﬁed as Yuexiandujisu F
[11] and Yuexiandajisu C [5], respectively. Compound 7 gave
[MþH]þ at m/z 319. The MS/MS spectrum showed losses of H2O,
CH3 and COOH. Thus, compound 7 was tentatively identiﬁed as
Yuexiandajisu A [4].
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